CVS Health dividend and valuation
Valuation
CVS Health paid $2.66 per share in dividends over the last 12 months (yield 3.1%). Last ex-dividend date: October 22, 2026. The P/E ratio is 10.4. The average price target of 26 analysts is $109.31.
What would CVS Health's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 17, 2026
CVS Health compared with similar companies
CVS Health's P/E (trailing 12 months): 10.4, −45% against the median of a group of 7 similar companies (18.9).
| Metric | CVS Health | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 10.4 | 18.9 | 11.9 – 23.2 | Low |
| Forward P/E | 10.2 | 14.3 | 9.81 – 16.2 | Middle |
| EV/EBITDA | 10.1 | 9.85 | 8.65 – 12.3 | Middle |
| Price/book | 1.41 | 2.15 | 1.69 – 2.42 | Low |
| Price/sales | 0.27 | 0.32 | 0.28 – 0.65 | Low |
| Gross margin | 13.7% | 13.7% | 12.5% – 22.5% | Middle |
| Operating margin | 3.1% | 3.9% | 2.7% – 4.9% | Middle |
| Net margin | 2.6% | 2.5% | 1.6% – 3.1% | Middle |
| ROE | 14.4% | 14.4% | 9.2% – 16.3% | Middle |
| Debt/equity | 0.93 | 0.70 | 0.69 – 0.75 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
CVS Health: valuation over time
On the latest fiscal year's earnings (2025), CVS Health's P/E today is 62.1, above the median of its last 9 fiscal years (14.6; between 11.3 and 57.1 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (3.1%) is in line with the median of the last 10 fiscal years (2.8%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | $79.36 | $1.39 | 57.1 | $2.66 | 3.4% |
| 2024 | $44.89 | $3.66 | 12.3 | $2.66 | 5.9% |
| 2023 | $78.96 | $6.47 | 12.2 | $2.42 | 3.1% |
| 2022 | $93.19 | $3.26 | 28.6 | $2.20 | 2.4% |
| 2021 | $103.16 | $6.02 | 17.1 | $2.00 | 1.9% |
| 2020 | $68.30 | $5.46 | 12.5 | $2.00 | 2.9% |
| 2019 | $74.29 | $5.08 | 14.6 | $2.00 | 2.7% |
| 2018 | $65.52 | -$0.57 | — | $2.00 | 3.1% |
| 2017 | $72.50 | $6.44 | 11.3 | $2.00 | 2.8% |
| 2016 | $78.91 | $4.90 | 16.1 | $1.70 | 2.2% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $113.35B
- Enterprise value
- $173.95B
- PEG
- 0.22
- EV/revenue
- 0.42
Profitability and growth
- ROA
- 3.1%
- Revenue growth (year over year)
- 5.4%
Financial health
- Total cash
- $14.89B
- Total debt
- $75.3B
- Current ratio
- 0.85
- Quick ratio
- 0.61
Dividends
- Annual dividend per share
- $2.66
- Dividend yield
- 3.1%
- Payout ratio
- 31.1%
- Ex-dividend date
- October 22, 2026
Analysts and estimates
- Average price target
- $109.31
- Median price target
- $109.00
- High price target
- $146.00
- Low price target
- $86.00
- Analysts with a price target
- 26
- Consensus
- Strong buy
- Forward EPS
- $8.70
- EPS estimate, current year
- $8.28
Shares and trading
- Beta
- 0.58
- Average volume
- 8.95M
- Shares outstanding
- 1.28B
- Float
- 1.28B
- Institutional ownership
- 90.4%
- Insider ownership
- 0.3%
- Short interest (% of float)
- 1.4%
- Short ratio (days)
- 2.13
